Jim Simons Precigen, Inc. Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Precigen, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,067,645 shares of PGEN stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,067,645
Previous 1,600,190
33.28%
Holding current value
$1.87 Million
Previous $1.52 Million
21.38%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PGEN
# of Institutions
144Shares Held
160MCall Options Held
136KPut Options Held
4.8K-
Third Security, LLC83.5MShares$146 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$31.3 Million1.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$19 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$17.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$14.6 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $364M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...